Form 497 SEPARATE ACCOUNT VA BNY
Transamerica PrincipiumSM III
Issued by
TRANSAMERICA LIFE INSURANCE COMPANY
SEPARATE ACCOUNT VA B
Issued by
TRANSAMERICA FINANCIAL LIFE INSURANCE COMPANY
SEPARATE ACCOUNT VA BNY
Supplement dated September 30, 2022
to the
Prospectus dated May 1, 2022
Effective on or about November 1, 2022, based on changes to the underlying portfolios, the following name and subadvisor changes will occur:
Current Portfolio Name | New Portfolio Name | Current Subadvisor | New Subadvisor | |||
Transamerica Managed Risk - Balanced ETF VP | Transamerica Goldman Sachs Managed Risk - Balanced ETF VP | Milliman Financial Risk Management LLC | Goldman Sachs Asset Management, L.P. | |||
Transamerica Managed Risk - Conservative ETF VP | Transamerica Goldman Sachs Managed Risk - Conservative ETF VP | Milliman Financial Risk Management LLC | Goldman Sachs Asset Management, L.P. | |||
Transamerica Managed Risk - Growth ETF VP | Transamerica Goldman Sachs Managed Risk - Growth ETF VP | Milliman Financial Risk Management LLC | Goldman Sachs Asset Management, L.P. |
Effective on or about November 1, 2022, based on changes to the underlying portfolios, the following name and subadvisor changes will occur:
Current Investment Objective |
New Investment Objective |
Current Portfolio Name |
New Portfolio Name |
Current Subadvisor |
New Subadvisor | |||||
Seeks maximum total return consistent with preservation of capital and prudent investment management | Seeks to provide high total return through a combination of current income and capital appreciation | Transamerica PIMCO Total Return VP | Transamerica Aegon Bond VP | Pacific Investment Management Company LLC | Aegon USA Investment Management, LLC |
This Supplement updates certain information in the above referenced prospectus (the Prospectus). Except as indicated in this Supplement, all other information included in the Prospectus remains unchanged. We will send you another copy of the current Prospectus or any supplement without charge upon request. Please contact our Administrative Office referenced in the Prospectus.
This Supplement must be accompanied or preceded by the current Prospectus.
Please read this Supplement carefully and retain it for future reference.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Robbins LLP Reminds IRobot Corporation Shareholders of the Pending May 7, 2024 Lead Plaintiff Deadline
- ROSEN, A LEADING AND TOP RANKED LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC
- YPF SA reports
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!